Trial intelligence / Profile preview

Dexamethasone Insert vs Topical Prednisolone in Cataract and Glaucoma Surgery

NCT04563559Phase 3Withdrawn

Sponsor
Duke University
Start
Nov 2020
Primary completion
Nov 2021
Modality
Small Molecules, Device-based Delivery
01

Overview

Phase 3, randomised, open-label trial of dexamethasone iontophoretic patch in post-operative inflammation and postoperative pain, sponsored by Duke University. Primary endpoints: Percent of patients who stated they preferred dexamethasone insert and Percent of patients who stated they preferred topical prednisolone insert. Planned start Nov 2020; status: withdrawn.

02

Drugs

dexamethasone iontophoretic patch
03

Conditions

post-operative inflammationpostoperative pain

Beyond the preview

Go deeper on NCT04563559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04563559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call